Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Selecta Biosciences Inc. (SELB)

4.16   0.11 (2.72%) 02-14 16:00
Open: 4.04 Pre. Close: 4.05
High: 4.42 Low: 3.97
Volume: 589,690 Market Cap: 359M
Selecta Biosciences Inc is a clinical-stage biopharmaceutical company using its proprietary synthetic vaccine particle technology to discover & develop targeted therapies designed to modulate the immune system to treat rare and serious diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.428 - 4.449 4.449 - 4.468
Low: 3.922 - 3.945 3.945 - 3.965
Close: 4.121 - 4.16 4.16 - 4.195

Technical analysis

as of: 2020-02-14 4:32:26 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 5.64     One year: 6.59
Support: Support1: 3.51    Support2: 2.70
Resistance: Resistance1: 4.83    Resistance2: 5.64
Pivot: 3.81
Moving Average: MA(5): 4.24     MA(20): 3.68
MA(100): 2.16     MA(250): 2.10
MACD: MACD(12,26): 0.44     Signal(9): 0.43
Stochastic oscillator: %K(14,3): 65.10     %D(3): 70.58
RSI: RSI(14): 66.48
52-week: High: 4.83  Low: 1.28  Change(%): 114.4
Average Vol(K): 3-Month: 61950  10-Days: 83708

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
SELB has closed below upper band by 35.5%. Bollinger Bands are 215.7% wider than normal. The large width of the bands suggest high volatility as compared to SELB's normal range. The bands have been in this wide range for 38 bars. This is a sign that the current trend might continue.

Headline News

The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) AbbVie Inc (NYSE: ABBV ) Allergan plc (NYSE: AGN ) )(reacted to better-than-expected results and comments that its deal to be acquired by AbbVie is on track to close by the first quarter) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Aptose Biosciences Inc (NASDAQ: APTO ) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Ascendis Pharma A/S (NASDAQ: ASND ) AtriCure Inc. (NASDAQ: ATRC ) ChemoCentryx Inc (NASDAQ: CCXI ) Co-Diagnostics Inc (NASDAQ: CODX )(announced sales of its new coronavirus test ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Insulet Corporation (NASDAQ: PODD ) Kodiak Sciences Inc (NASDAQ: KOD )(reacted to positive data readout from early-stage study of experimental drug to treat eye disorders) Masimo Corporation (NASDAQ: MASI ) Novartis AG (NYSE: NVS ) Pacira Biosciences Inc (NASDAQ: PCRX ) Principia Biopharma Inc (NASDAQ: PRNB ) PTC Therapeutics, Inc (NASDAQ: PTCT ) Revance Therapeutics Inc (NASDAQ: RVNC ) ResMed Inc.

ObsEva and Selecta Bio up premarket on bullish ratings
ObsEva (NASDAQ:OBSV) initiated with Buy rating and $19 (395% upside) price target at Kempen & Co. Shares up 8% premarket. Selecta Biosciences (NASDAQ:SELB)

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 86.33
Shares Float (M) 28.63
% Held by Insiders 31.50
% Held by Institutions 95.78
Shares Short (K) 816
Shares Short P. Month (K)

Stock Financials

EPS -1.448
Book Value (p.s.) -0.100
PEG Ratio
Profit Margin
Operating Margin -5873.00
Return on Assets (ttm) -68.1
Return on Equity (ttm) -2167.7
Qtrly Rev. Growth
Gross Profit (p.s.) -0.302
Sales Per Share
EBITDA (p.s.) -0.622
Qtrly Earnings Growth
Operating Cash Flow (M) -51.31
Levered Free Cash Flow (M) -65.40

Stock Valuations

P/E -2.87
P/E Growth Ratio 0.03
P/BV -41.60
P/S 208.00
P/CF -7.00

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.